American Clinical Laboratory Association (ACLA)

ACLA_new.gifThe American Clinical Laboratory Association (ACLA) is the clinical laboratory industry's leading advocate providing effective communication with Congress, regulatory bodies, other health care organizations and the public.  A not-for-profit association, ACLA represents the nation's leading national and regional clinical laboratories on key issues of common concern, including federal and state government reimbursement and regulatory policies. Its primary purpose is to: advocate laws and regulations that recognize the essential role that laboratory services play in delivering cost-effective health care; encourage the highest standards of quality, service and ethical conduct among its members; and promote public awareness about the value of laboratory services in preventing illness, diagnosing disease, and monitoring medical treatment.

Comment on Genetic Testing Before Senate Special Committee on Aging Genetic Testing Roundtable

On June 12, 2008 the Senate Special Committee Aging held a Genetic Test Roundtable Discussion.  Dr. Elaine Lyon, Medical Director of Molecular Genetics at ARUP Laboratories represented ACLA on a panel that included representatives from FDA, CMS, the National Human Genome Research Institute, the Johns Hopkins Genetics and Public Policy Center and web based company 23andMe. The roundtable was organized by Senator Gordon Smith (R-OR), as a follow-up to a 2006 Congressional Hearing on Nutrigenetic Testing held by this committee.  In his opening remarks, Senator Smith referred back to the 2006 Hearing which revealed questionable practices related to some direct to consumer genetic tests. He described the purpose of this briefing as an opportunity to revisit the safety and effectiveness of these tests and to determine whether additional protection is needed for consumers.